Default company panoramic image

Stabiliz Orthopaedics

Stabiliz was formed to develop disruptive technologies in the orthopedic space utilizing FDA approved materials, providing a quick path to revenue.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Narberth, PA, USA
  • Currency USD
  • Employees 4
  • Website

Company Summary

Susan Harding, MD (Chief Orthopedic Trauma Surgeon, Hahneman Hospital) and Douglas Cerynik, MD (Director of Orthopedic Research, Drexel College of Medicine) conceptualized the initial products using FDA approved bio-resorbable materials to modify existing fracture plate systems, thus improving their clinical effectiveness. Stabiliz aims to foster greater clinical outcomes for traumatic fracture patients, ultimately reducing treatment costs.


  • Default avatar
    Douglas Cerynik, MD, MBA
    President and CEO

  • Default avatar
    Bradley Grossman, MBA
    VP of Operations

  • Default avatar
    Michael Adelizzi, MBA
    VP of Research and Development

  • Default avatar
    Susan Harding, MD
    VP of Clinical Development


  • Default avatar
    Ballard Spahr, Jennifer Miller, John Chionchio
    Default avatar
    Ed Plasky, Gold, Gocial & Gerstein

Previous Investors

  • Default avatar
    Baiada Center, Drexel University|Ben Franklin Technology Partners|Kevin Heerdt - Angel Investor